Related Experiment Video
Updated: Nov 4, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
Skin Cancers and Lung Transplant
Reason Wilken1, John Carucci1, Mary L Stevenson1
1The Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, New York.
Solid-organ transplant recipients face a significantly higher risk of skin cancer, particularly nonmelanoma skin cancers (NMSCs). Early detection and management are crucial for improving outcomes in this high-risk group.
Area of Science:
- Dermatology
- Oncology
- Transplantation Medicine
Background:
- Solid-organ transplant recipients (SOTRs) exhibit a 65- to 100-fold increased risk of skin cancer, including nonmelanoma skin cancers (NMSCs) like cutaneous squamous cell carcinoma (cSCC) and basal cell carcinoma (BCC).
- SOTRs with NMSC, especially cSCC, face poorer prognoses, with higher rates of recurrence, metastasis, and disease-specific mortality compared to non-immunosuppressed individuals.
- Lung transplant recipients, due to intense immunosuppression, are particularly vulnerable and require heightened surveillance for aggressive skin malignancies.
Purpose of the Study:
- To provide a comprehensive overview of cutaneous malignancy risks in organ transplant recipients.
- To detail the role of immunosuppressive and prophylactic medications in increasing skin cancer risk, focusing on NMSC in lung transplant recipients.
- To discuss clinical and dermatologic management strategies for high-risk immunosuppressed patients, including field therapy and chemoprevention.
Main Methods:
- Review of risk factors for cutaneous malignancies in organ transplant recipients.
- Analysis of immunosuppressive and prophylactic agents contributing to skin cancer development.
- Discussion of clinical and dermatologic management, including topical/systemic therapies and preventive measures.
Main Results:
- SOTRs have a substantially elevated risk of developing various skin cancers, including NMSCs, melanoma, and rarer malignancies.
- NMSC in SOTRs is associated with significantly worse clinical outcomes, such as metastasis and increased mortality.
- Lung transplant recipients represent a particularly high-risk subgroup requiring specialized monitoring.
Conclusions:
- Increased surveillance, awareness of risk factors, and proactive management are essential for improving outcomes in SOTRs with cutaneous malignancies.
- Understanding the contribution of immunosuppressive medications is key to managing skin cancer risk in this population.
- Comprehensive dermatologic care, including field therapy and chemoprevention, is vital for preventing and treating skin cancers in immunosuppressed transplant recipients.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Kidney Transplant II: Surgical Procedure

